1-6 of 6
liposomes
Close
Save search
Sort by
Journal Articles

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

Free
Clinical Trials & Observations
Sirpa Leppä, Judit Jørgensen, Anne Tierens, Leo Meriranta, Ingunn Østlie, Peter de Nully Brown, Unn-Merete Fagerli, Thomas Stauffer Larsen, Susanna Mannisto, Lars Munksgaard, Martin Maisenhölder, Kaija Vasala, Peter Meyer, Mats Jerkeman, Magnus Björkholm, Øystein Fluge, Sirkku Jyrkkiö, Knut Liestøl, Elisabeth Ralfkiaer, Signe Spetalen, Klaus Beiske, Marja-Liisa Karjalainen-Lindsberg, Harald Holte
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1906–1915.
https://doi.org/10.1182/bloodadvances.2020001518
Published: 2020
Includes: Supplemental data
Journal Articles

Dual-action CXCR4-targeting liposomes in leukemia: function blocking and drug delivery

Free
Catriona McCallion, Anna D. Peters, Andrew Booth, Karen Rees-Unwin, Julie Adams, Raisa Rahi, Alain Pluen, Claire V. Hutchinson, Simon J. Webb, John Burthem
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2069–2081.
https://doi.org/10.1182/bloodadvances.2019000098
Published: 2019
Includes: Supplemental data
Journal Articles

Generation of transgenic zebrafish with 2 populations of RFP- and GFP-labeled thrombocytes: analysis of their lipids

Free
Weam Fallatah, Imesha W. De Silva, Guido F. Verbeck, Pudur Jagadeeswaran
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1406–1415.
https://doi.org/10.1182/bloodadvances.2018023960
Published: 2019
Includes: Supplemental data
Journal Articles

Ocular instillation of vitamin A–coupled liposomes containing HSP47 siRNA ameliorates dry eye syndrome in chronic GVHD

Free
Clinical Trials & Observations
Hiroyuki Ohigashi, Daigo Hashimoto, Eiko Hayase, Shuichiro Takahashi, Takahide Ara, Tomohiro Yamakawa, Junichi Sugita, Masahiro Onozawa, Masao Nakagawa, Takanori Teshima
Journal: Blood Advances
Blood Adv (2019) 3 (7): 1003–1010.
https://doi.org/10.1182/bloodadvances.2018028431
Published: 2019
Journal Articles

The role of targeted therapy in the management of patients with AML

Free
Clinical Trials & Observations
Alexander E. Perl
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2281–2294.
https://doi.org/10.1182/bloodadvances.2017009829
Published: 2017
Journal Articles

Sphingomyelin encrypts tissue factor: ATP-induced activation of A-SMase leads to tissue factor decryption and microvesicle shedding

Free
Jue Wang, Usha R. Pendurthi, L. Vijaya Mohan Rao
Journal: Blood Advances
Blood Adv (2017) 1 (13): 849–862.
https://doi.org/10.1182/bloodadvances.2016003947
Published: 2017
Includes: Supplemental data